![]() Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. | ||
Founding Date | Founding Date 1997 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Planegg, DE HQ | Locations Cambridge, US HQ |
Employees | Employees 13 | Employees 20364% increase |
Valuation ($) | Valuation ($) 74 m | Valuation ($) 250.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) €2.6m (FY, 2025) | Revenue (est.) $37.4m (FY, 2021) |
Cost of goods | Cost of goods €45k (FY, 2025) | Cost of goods $10.5m (FY, 2021) |
Net income | Net income (€3.5m) (FY, 2025) | Net income ($251.1m) (FY, 2021) |

Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
View company